Phase III Study of HP-3150 in Patients with Humeroscapular Periarthritis, Cervico-omo-brachial Syndrome and Tenosynovitis
Latest Information Update: 20 Dec 2021
At a glance
- Drugs Diclofenac (Primary)
- Indications Pain
- Focus Therapeutic Use
- Acronyms LP04
- Sponsors Hisamitsu Pharmaceutical
- 14 Dec 2020 New trial record
- 07 Dec 2020 According to a Hisamitsu Pharmaceutical media release, the company has announced the data from this study. The company states that this study has met its primary end point.